Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on MMA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced organocatalytic method for chiral gamma-amino acids. Reduces cost in API manufacturing with high enantioselectivity. Reliable pharmaceutical intermediate supplier.
Patent CN117701649B reveals enzymatic DKR for Brivaracetam intermediates. Achieve 99% ee and reduced costs. Reliable pharmaceutical intermediate supplier for scale-up.
Discover a novel palladium-catalyzed asymmetric allylic cycloaddition method for synthesizing chiral oxygen-containing eight-membered rings with high yield and enantioselectivity.
Discover a novel metal-free synthesis method for 3-acyl indoles via nucleophilic organocatalysis. Achieve high purity and cost reduction in API manufacturing with scalable processes.
Patent CN107384980A reveals efficient Reformatsky and lipase resolution for beta-hydroxy-gamma-amino acids, offering cost reduction and supply reliability for pharma intermediates.
Discover high-purity indole-dihydronaphthalene intermediates via novel Rh/Pd dual catalysis. Enhanced enantioselectivity and cost-effective manufacturing for pharma.
Patent CN115572310A reveals a solvent-free Bronsted acid catalyzed method for synthesizing alpha,alpha-disubstituted-gamma-ketophosphine oxides with high atom economy.
Patent CN103130802B enables high-yield synthesis. Delivers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN114349703B reveals a novel silver-catalyzed route for trifluoromethyl-4-cyano pyrazole compounds, offering superior regioselectivity and scalable manufacturing for pharmaceutical supply chains.
Patent CN114835580B reveals metal-free gamma-deuteration method. Enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing with high purity.
Advanced one-step process for high-purity dexamethasone sodium phosphate. Reduces production costs and enhances supply chain reliability for API manufacturing.
Patent CN1030073A details a safe, three-step synthesis of 3-amino-2-methyltrifluorotoluene, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN111362973A details a cost-effective, one-step copper-catalyzed route to 1,2-benzothiazine derivatives, offering significant advantages for pharmaceutical intermediate manufacturing.
Patent CN114890908B reveals a catalytic method for gamma-trifluoromethyl amino acids using Togni reagents, offering cost reduction in API manufacturing and scalable production.
Patent CN101768141A details a safer solvent-free synthesis route. Achieve high purity and reduced environmental impact for pharmaceutical intermediate supply chains.
Novel gamma-butyrolactone route for 3-hydroxymethyl tetrahydrofuran. High yield, low cost agrochemical intermediate manufacturing process suitable for industrial scale-up.
Patent CN114605272A details a novel Nickel-catalyzed asymmetric hydrogenation route for (R)-Fluoxetine intermediates, offering significant cost reduction and high enantioselectivity for API manufacturing.
Advanced synthesis of benzopyran derivatives for inflammation treatment. Patent CN1041311C offers cost-effective routes for high-purity pharmaceutical intermediates.
Patent CN113754616A details a high-yield synthesis of trans-3-thiophenyl-gamma-lactone. Discover cost-effective manufacturing and supply chain advantages for flavor intermediates.
Patent CN108047172B details a novel catalytic method for converting biomass-based levulinic acid into high-purity pharmaceutical intermediates with improved yield.